Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Agnes Charpentier
Dyserythropoiesis Evaluated by RED Score and Hepcidin/Ferritin Levels Predicts Response to Erythropoietin in Lower Risk Myelodysplastic Syndromes
Haematologica
Hematology
Related publications
Relationship of Treatment-Related Cytopenias and Response to Lenalidomide in Patients With Lower-Risk Myelodysplastic Syndromes
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Correction To: The Prognostic Value of Serum Erythropoietin in Patients With Lower-Risk Myelodysplastic Syndromes: A Review of the Literature and Expert Opinion
Annals of Hematology
Medicine
Hematology
High Serum Erythropoietin and Ferritin Levels Associated With Anemia Response in Malignant Lymphoma
Mediterranean Journal of Hematology and Infectious Diseases
Infectious Diseases
Hematology
Flow Cytometric Detection of Dyserythropoiesis: A Sensitive and Powerful Diagnostic Tool for Myelodysplastic Syndromes
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Mutations and Karyotype Predict Treatment Response in Myelodysplastic Syndromes
American Journal of Hematology
Hematology
Treatment of Anemia in Low Risk Myelodysplastic Syndromes With Granulocyte–macrophage Colony-Stimulating Factor Plus Recombinant Human Erythropoietin
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Long-Term Outcome of Immunosuppressive Therapy for Japanese Patients With Lower-Risk Myelodysplastic Syndromes
International Journal of Hematology
Hematology
Polymorphism of the Erythropoietin Gene Promotor and the Development of Myelodysplastic Syndromes Subsequent to Multiple Myeloma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
